Ellevest Inc’s MacroGenics MGNX Stock Holding History

Ellevest Inc’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-18	Closed	-$129	–	1111
2023 Q1	$129	Hold	18	–	–	﹤0.01%	1798
2022 Q4	$121	Buy	+18	New	+$99	﹤0.01%	1743

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ellevest Inc's MGNX Position: Q2 2023 in Review

Ellevest Inc sold out of MacroGenics (MGNX) in Q2 2023, closing a stake of 18 shares — an estimated $129 sold.

Ellevest Inc first reported a position in MGNX in Q4 2022 and held it in 2 quarters. The position peaked at $129 in Q1 2023. 131 funds tracked by Wall St. Rank hold MGNX as of Q2 2023.

Ellevest Inc reported no remaining MacroGenics position as of Q2 2023 after selling out during the quarter.
Ellevest Inc sold 18 MacroGenics shares in Q2 2023, an estimated $129.
Ellevest Inc first reported a position in MacroGenics in Q4 2022 and held it in 2 quarters.
Ellevest Inc's MacroGenics position peaked at $129 in Q1 2023.
131 funds tracked by Wall St. Rank held MacroGenics as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.